HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
about
IRF7: activation, regulation, modification and functionThe A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7Herpes simplex virus 1 DNA polymerase processivity factor UL42 inhibits TNF-α-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1Ubiquitin in the activation and attenuation of innate antiviral immunityThe role of ubiquitylation in immune defence and pathogen evasionHSV-1 ICP0: paving the way for viral replicationMBD4 interacts with and recruits USP7 to heterochromatic fociCrystal Structure of USP7 Ubiquitin-like Domains with an ICP0 Peptide Reveals a Novel Mechanism Used by Viral and Cellular Proteins to Target USP7The HBx oncoprotein of hepatitis B virus deregulates the cell cycle by promoting the intracellular accumulation and re-compartmentalization of the cellular deubiquitinase USP37.Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responsesHSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination.A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigsDeubiquitinating enzymes as promising drug targets for infectious diseases.HSV-1 ICP0: An E3 Ubiquitin Ligase That Counteracts Host Intrinsic and Innate ImmunityNovel roles of cytoplasmic ICP0: proteasome-independent functions of the RING finger are required to block interferon-stimulated gene production but not to promote viral replication.Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-κB activation.Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signalingHerpes simplex virus glycoproteins gH/gL and gB bind Toll-like receptor 2, and soluble gH/gL is sufficient to activate NF-κBA vaccinia virus deletion mutant reveals the presence of additional inhibitors of NF-kappaB.A herpesvirus virulence factor inhibits dendritic cell maturation through protein phosphatase 1 and Ikappa B kinase.Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in miceEpstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signalingActivation and evasion of innate antiviral immunity by herpes simplex virusA survey of the interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny virusesVaricella-zoster virus inhibition of the NF-κB pathway during infection of human dendritic cells: role for open reading frame 61 as a modulator of NF-κB activityActivation of NF-κB in CD8+ dendritic cells Ex Vivo by the γ134.5 null mutant correlates with immunity against herpes simplex virus 1.Deubiquitination of NF-κB by Ubiquitin-Specific Protease-7 promotes transcription.Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.Interaction of herpes simplex virus ICP0 with ND10 bodies: a sequential process of adhesion, fusion, and retentionHerpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1.Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling.Recognition of herpes simplex viruses: toll-like receptors and beyondConstitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors.HSV Recombinant Vectors for Gene Therapy.The multifaceted roles of USP7: new therapeutic opportunities.Viral takeover of the host ubiquitin system.Herpes simplex activation prolongs recovery from severe burn injury and increases bacterial infection risk.Regulation of NF-κB by deubiquitinases.Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.Herpesviruses: interfering innate immunity by targeting viral sensing and interferon pathways.
P2860
Q24299740-7D7A9AFE-2FAB-4C2C-839E-C21478BB80F9Q24306662-115A93C9-80B2-4BF5-8F02-3430C4664752Q24339512-74F5D7A0-CD69-4403-82A5-8DB43F1E6EA0Q26771789-0E808F3C-2199-4E1B-BD23-1C5BAE9AB196Q26860775-BD02B1DE-302D-44AE-AD9D-F7AFCDC6E8B0Q28243426-ACC4627F-3991-4EE0-90EC-549FC2E43A6BQ28250621-6D878887-A6A2-4D41-B30E-E8FC05E99B9AQ28547943-44B5D031-41AC-4BB2-B60B-D5F26F8C2311Q30409927-E5AAEAE9-F0B3-41AF-80F1-BA4017E7C1CAQ33573566-5ECBB811-D9A4-45C2-AFDF-8F57E524CDBCQ33720245-E4807C65-0123-448D-A864-9EE36FC838CAQ33825931-482B14BA-4D5F-4A59-877C-70EB336B0B02Q33836097-10C41FA6-3F29-41F1-8C2E-71CCDCE614A5Q33883877-C87FB110-0751-47E2-8C08-01FAB02B2FD2Q33900347-93491EA7-B8BD-4738-A406-0C908505EDB0Q33900418-DBC87546-0A7B-4F37-89F7-5211866262F3Q34178155-8229E564-FCFB-401A-B440-3A646F61C5C4Q34267595-5CC9A512-6AC8-49A5-A541-0709F99E25C8Q34485252-F184C3CE-6E36-4FE3-81FB-0138F890A0C4Q34742621-2203EE46-5C1D-4F3D-8FB9-37C56E9C4963Q35076638-93DFEC55-1A47-42F5-A17E-E2D24DD70ECDQ35105647-3886577F-C300-49E9-B7DD-D569CE59EFB1Q35259878-5FDD7670-7140-4A4C-89EF-E78389B9DCE3Q35489050-7BFC1ECB-D9B3-4E42-80AC-358FEF9EE6F4Q35665805-E1284A97-EFB6-40E9-BD37-1092279E774EQ35665813-BC601EE0-D10D-4D9B-9670-BFD726475E25Q36535326-25F0E8DD-7885-41CD-AD3E-D906F0CECB9BQ36951802-D221A36E-3F7F-4B97-97D0-F4D20FECF8F5Q37123088-FC991017-7299-4E0A-8DC0-F8CD550702D7Q37336427-88134C3E-DB5C-4A1E-BEE0-12ACB376073DQ37575463-7A856ED3-9C8A-4DE7-A187-6EBA180DC591Q37619828-251FB5A4-B331-41CF-B6BD-4BC5E48F5DFBQ37784704-3B59F7EA-5749-4FC4-9549-2D8060A93052Q37787777-844BD08E-EEAC-41AC-B945-714F491887DAQ37862125-135BA649-9ED0-439A-A004-F77AFF84C1A5Q37918803-950DF87B-446B-4546-8587-03DACCDB255BQ37955615-DFE72A22-E19F-48AE-9067-579DCB4A5345Q37995682-08AF8C42-F6B9-4D64-8855-D4C46C6C029AQ38241377-C1D289A4-1357-4B70-B279-63421CE0F994Q38408315-02474471-EABE-45FD-96C2-2D98C324FF5A
P2860
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
@ast
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
@en
type
label
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
@ast
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
@en
prefLabel
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
@ast
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
@en
P2093
P2860
P1433
P1476
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
@en
P2093
Divyendu Singh
Hongiu Liu
Howard J Federoff
Khaled Tolba
Sandrine Daubeuf
William J Bowers
Yaohong Tan
P2860
P304
P356
10.1182/BLOOD-2008-07-168203
P407
P577
2008-10-24T00:00:00Z